📰 AMGEN LUMAKRAS STUDY GOAL ISN’T CLEAR, FDA ADVISORY PANEL VOTES $AMGN

AMGEN LUMAKRAS STUDY GOAL ISN’T CLEAR, FDA ADVISORY PANEL VOTES $AMGN